Sam Eshun

Prior to joining ACP in 2022, Samuel worked for CSL Behring, a biotech company specializing in plasma-derived therapies for rare diseases. He was also an Industrials Analyst for Drexel University’s Endowment Fund. Sam is a graduate of the LeBow College of Business at Drexel University, where he earned a B.S. in Finance & Business Analytics.